|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0008 USD | -96.36% |
|
0.00% | -99.07% |
| Jan. 17 | Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
| 2023 | Innovation1 Biotech Inc. announced that it has received $0.15 million in funding | CI |
Innovation1 Biotech Inc. filed its 10-K on Dec 15, 2022 for the period ending Aug 31, 2022. In this report its auditor, Fruci & Associates II, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
| 1st Jan change | Capi. | |
|---|---|---|
| -99.07% | 17.98K | |
| +137.37% | 5.68B | |
| +1.89% | 1.01B | |
| +2.19% | 982M | |
| +41.91% | 872M | |
| +25.27% | 819M | |
| +1.68% | 663M | |
| +0.54% | 610M | |
| -.--% | 600M | |
| +21.31% | 552M |
INNOVATION1 BIOTECH INC. 
